Skip to main content
SpringerLink
Log in

Pharmacoclinical data on high dose medroxyprogesterone acetate in advanced breast cancer

  • Brief Communication
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Johnson JR, Priestman TJ, Fotherby K, Kelly KA, Priestman SG: An evaluation of high-dose medroxyprogesterone acetate (MPA) therapy in women with advanced breast cancer. Br J Cancer 50: 363–366, 1984

    PubMed  Google Scholar 

  2. Pannuti F, Camaggi GM, Strocchi E, and 5 others: Medroxyprogesterone acetate pharmacokinetics. In: Pelligrini A et al. (eds): Role of Medroxyprogesterone in Endocrine-Related Tumors, Vol. 3. Raven Press, New York, 1984, pp 43–77

    Google Scholar 

  3. Hedley DW, Christie MD, Weatherby RP, Caterson ID: Lack of correlations between plasma concentration of medroxyprogesterone acetate, hypothalamic-pituitary function, and tumour response in patients with advanced breast cancer. Cancer Chemother Pharmacol 14: 112–115, 1985

    PubMed  Google Scholar 

  4. Tamassia V, Battaglia A, Ganzina F and 7 others: Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology. Cancer Chemother Pharmacol 8: 151–156, 1982

    PubMed  Google Scholar 

  5. Milano G, Carle G, Renée N, Boublil JL, Namer M: Determination of medroxyprogesterone acetate in plasma by high performance liquid chromatography. J Chromatogr 232: 413–417, 1983

    Google Scholar 

  6. McGuire WL, De La Garza M, Chamness GC: Evaluation of estrogen receptor assays in human breast cancer tissue. Cancer Res 37: 637–642, 1977

    PubMed  Google Scholar 

  7. Milano G, Moll JL, Formento JL, Francoual M, and 4 others: Simultaneous micro-measurement of steroid receptors in breast cancer. Brit J Cancer 48: 579–584, 1983

    PubMed  Google Scholar 

  8. Cortes Funes H, Madrigal PL, Perez Mangas GP, Mendiola C: Medroxyprogesterone acetate at two different high doses for the treatment of advanced breast cancer. In: Campio L, Robustelli Della Cuna G, Taylor RW (eds): Role of Medroxyprogesterone in Endocrine-Related Tumors. Raven Press, New York, 1983, pp 77–83

    Google Scholar 

  9. Van Veelen H, Willemse PHB, Van der Ploeg E, Sluiter WJ, Doorenbos H: Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients. Cancer Chemother Pharmacol 15: 143–170, 1985

    Google Scholar 

  10. Iacobelli S, Sica G, Natoli C, Gatti D: Inhibitory effects of medroxyprogesterone acetate on the proliferation of human breast cancer cells. In: Campio L, Robustelli Della Cuna G, Taylor RW (eds): Role of Medroxyprogesterone in Endocrine-Related Tumors. Vol. 2, Raven Press, New York, 1983, pp 1–6

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Oncology Dept., Centre Antoine Lacassagne, 36 Voie Romaine, 06054, Nice, France

    Moise Namer, Roger Khater, Marc Frenay & Antoine Thyss

  2. Pharmacokinetics Laboratory, Centre Antoine Lacassagne, 36 Voie Romaine, 06054, Nice, France

    Gérard Milano & Nicole Renée

Authors
  1. Moise Namer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gérard Milano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roger Khater
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marc Frenay
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antoine Thyss
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nicole Renée
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Namer, M., Milano, G., Khater, R. et al. Pharmacoclinical data on high dose medroxyprogesterone acetate in advanced breast cancer. Breast Cancer Res Tr 8, 161–163 (1986). https://doi.org/10.1007/BF01807705

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01807705

Keywords

Search

Navigation